Efficacy and safety of ziltivekimab in patients with chronic kidney disease susceptible to inflammatory diseases: a systematic review and meta-analysis of randomized controlled trials.
Saved in:
| Title: | Efficacy and safety of ziltivekimab in patients with chronic kidney disease susceptible to inflammatory diseases: a systematic review and meta-analysis of randomized controlled trials. |
|---|---|
| Authors: | Elrosasy, Amr1 (AUTHOR), Sabbagh, Dalal2 (AUTHOR), Assaf, Mohammad3 (AUTHOR), Tarakhan, Husam3 (AUTHOR), Afyouni, Ahmad4 (AUTHOR), Elgendy, Marwa O.5,6 (AUTHOR) marwa.elgendy@nub.edu.eg, Abdelaty, Lamiaa N.7 (AUTHOR), Omar, Refaat H.8,9 (AUTHOR) refaat.hussein@nub.edu.eg, Zabady, Ahmed Hamdy10 (AUTHOR) |
| Source: | Future Journal of Pharmaceutical Sciences. 11/26/2024, Vol. 10 Issue 1, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
